Scintigraphic Criteria for Radioablation of Small Thyroid Residua in Patients with Differentiated Thyroid Cancer

被引:0
|
作者
Dzhuzha, D. A. [1 ]
机构
[1] Natl Canc Inst, Kiev, Ukraine
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S431 / S431
页数:1
相关论文
共 50 条
  • [41] SCINTIGRAPHIC ASSESSMENT OF THYROID-CANCER
    BOYD, CM
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (07) : 1463 - 1463
  • [42] SCINTIGRAPHIC DEMONSTRATION OF THYROID CANCER METASTASES
    LAGARDE, C
    HIRTZ, G
    HUGUES, A
    LETREUT, A
    MAREE, D
    JOURNAL DE RADIOLOGIE D ELECTROLOGIE ET DE MEDECINE NUCLEAIRE, 1969, 50 (10): : 753 - &
  • [43] Scintigraphic visualization of glossal thyroid tissue during the follow-up of thyroid cancer patients
    Zanotti-Fregonara, Paolo
    Hindie, Elif
    Keller, Isabelle
    Calzada-Nocaudie, Marie
    Devaux, Jean-Yves
    CLINICAL NUCLEAR MEDICINE, 2007, 32 (12) : 911 - 914
  • [44] The limit of detection in scintigraphic imaging with I-131 in patients with differentiated thyroid carcinoma
    Haenscheid, H.
    Lassmann, M.
    Buck, A. K.
    Reiners, C.
    Verburg, F. A.
    PHYSICS IN MEDICINE AND BIOLOGY, 2014, 59 (10): : 2353 - 2368
  • [45] Incidental discovery of thyroid cancer in scintigraphic studies of patients with hyperparathyroidism
    Rodriguez Morales, V.
    Nunez de De Oliveira, B.
    Loira Bamio, F.
    Munoz, J.
    Renda, A.
    Martinez, C.
    Ruiz, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S615 - S615
  • [46] Preoperative thyroid-stimulating hormone associated risk of differentiated thyroid cancer in patients with thyroid nodules
    Al Essa, M.
    CELLULAR AND MOLECULAR BIOLOGY, 2021, 67 (03) : 85 - 91
  • [47] Usefulness of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma at first radioablation
    Garcia-Burillo, A.
    Kisel, N.
    Barios, M.
    Dellepiane, F.
    Gonzalez, J. M.
    Porta, F.
    Obiols, G.
    Castell, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S291 - S291
  • [48] Reevaluation of Criteria and Establishment of Models for Total Thyroidectomy in Differentiated Thyroid Cancer
    Wu, Zhenghao
    Xiao, Yunxiao
    Ming, Jie
    Xiong, Yiquan
    Wang, Shuntao
    Ruan, Shengnan
    Huang, Tao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Safety of denosumab in patients with refractory differentiated thyroid cancer and advanced medullary thyroid cancer.
    Wassermann, Johanna
    Mathy, Elise
    Lescaille, Geraldine
    Slim, Marine
    Buffet, Camille
    Saie, Clotilde
    Braik-Djellas, Yasmin
    Simon, Jean-Marc
    Menegaux, Fabrice
    Tresallet, Christophe
    Chami, Linda
    Lussey-Lepoutre, Charlotte
    Herve, Genevieve
    Bernier, Marie-Odile
    Spano, Jean-Philippe
    Leenhardt, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer
    Kim, Choon-Young
    Son, Seung Hyun
    Jung, Ji-hoon
    Kim, Do-Hoon
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    Ahn, Byeong-Cheol
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)